Form 4: Beam Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations

Christine Bellon, Chief Legal Officer of Beam Therapeutics, sold 385 shares of common stock to cover tax withholding obligations.

Summary

• Christine Bellon, the Chief Legal Officer of Beam Therapeutics Inc. (BEAM), sold 385 shares of common stock on October 1, 2024.
• The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units granted under the company's 2019 Equity Incentive Plan.
• The shares were sold at a weighted average price of $23.4794, with individual transactions ranging from $23.46 to $23.48.
• Following the transaction, Bellon directly owns 104,209 shares of Beam Therapeutics.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 19, 2023.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) by an officer, which is neither particularly positive nor negative.

Industry Context

This is a routine Form 4 filing, indicating insider transactions. It's common for executives to sell shares to cover tax obligations, especially after vesting of stock options or restricted stock units. The use of a 10b5-1 plan suggests the insider is selling shares in a pre-planned manner to avoid accusations of trading on inside information.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale and the relatively small number of shares involved.

Key Dates